Publications by authors named "Can Hekim"

Claim this Profile
C
Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia.
Sean I Tracy, Hrishi Venkatesh, Can Hekim, Lynn M Heltemes-Harris, Todd P Knutson

Blood· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic regulatory T cells arise via two distinct developmental programs.
David L Owen, Shawn A Mahmud, Louisa E Sjaastad, Jason B Williams, Justin A Spanier, Can Hekim

Nat Immunol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models.
Can Hekim, Mette Ilander, Jun Yan, Erin Michaud, Richard Smykla

Cancer Immunol Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open Letter in Support of Transformative Biotechnology and Social Innovation: SANKO University Innovation Summit in Medicine and Integrative Biology, Gaziantep, Turkey, May 5-7, 2016.
Eyüp İlker Saygılı, Alaa H Abou-Zeid, Salih Murat Akkın, Eleni Aklillu, İbrahim Ömer Barlas, Can Hekim, Nezih Hekim

OMICS· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteolytic activity of prostate-specific antigen (PSA) towards protein substrates and effect of peptides stimulating PSA activity.
Johanna M Mattsson, Suvi Ravela, Can Hekim, Magnus Jonsson, Johan Malm

PLoS One· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of peptides as protease inhibitors and stimulators.
Hannu Koistinen, Can Hekim, Ping Wu, Ale Närvänen, Ulf-Håkan Stenman

Methods Mol Biol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunology and immunotherapy of chronic myeloid leukemia.
Mette Ilander, Can Hekim, Satu Mustjoki

Curr Hematol Malig Rep· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mimetics of the disulfide bridge between the N- and C-terminal cysteines of the KLK3-stimulating peptide B-2.
Miikka Pakkala, Janne Weisell, Can Hekim, Jouko Vepsäläinen, Erik A A Wallen

Amino Acids· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex formation between human prostate-specific antigen and protease inhibitors in mouse plasma.
Can Hekim, Tero Riipi, Lei Zhu, Pirjo Laakkonen, Ulf-Håkan Stenman

Prostate· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides.
Can Hekim, Tero Riipi, Janne Weisell, Ale Närvänen, Riitta Koistinen

Biol Chem· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of peptides specifically modulating the activity of KLK2 and KLK3.
Hannu Koistinen, Ale Närvänen, Miikka Pakkala, Can Hekim, Johanna M Mattsson

Biol Chem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors.
Miikka Pakkala, Can Hekim, Pasi Soininen, Jari Leinonen, Hannu Koistinen

J Pept Sci· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel peptide inhibitors of human kallikrein 2.
Can Hekim, Jari Leinonen, Ale Närvänen, Hannu Koistinen, Lei Zhu

J Biol Chem· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
Altay Gezer, Turgay Atasü, Can Hekim, Ulf H Stenman, Nezih Hekim

Eur J Obstet Gynecol Reprod Biol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of incubation time on recognition of various forms of prolactin in serum by the DELFIA assay.
Can Hekim, Henrik Alfthan, Jari T Leinonen, Ulf-Håkan Stenman

Clin Chem· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Macroprolactinemia--a more common cause of hyperprolactinemia than generally believed].
Timo Sane, Can Hekim, Henrik Alfthan, Ulf-Håkan Stenman, Matti Välimäki

Duodecim· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis